Abstract

The in vitro anticancer screening of the medicated herbal formulation of podophyllum as reported earlier. The formulation of herbal syrup was prepared and optimized as per industrial practice guidelines and was subjected to in vitro anticancer assay against a A549-Human lung cancer cell line and MCF7-Huam Breast cancer cell line. The LC50, TGI and GI50 are reported here against standard Adriamycin used in the test. The result showed comparable activity of the herbal syrup of podophyllum extract.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call